HealthIT.com
Menu

Every claim we hold, and how far we can stand behind it.

142 claims across 39 products. 28% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.

Evidence classClaimsConfirmedWhat it can support
Peer-reviewed study195Reviewed before publication; assess study quality, funding, conflicts, and relevance to your setting.
Regulatory filing40A statement made to a regulator, where being wrong has consequences.
Independent report329Reporting outside a vendor publication; assess underlying data, sponsorship, and conflicts separately.
Customer case43A real deployment, but selected and framed by someone with an interest.
Press release6322The vendor's own announcement. Useful for dates and facts, not for outcomes.
Vendor page201Marketing copy. Establishes what is claimed, never that it is true.

Showing 1 of 1 matching claims (142 in the full corpus) · 0% of this selection is confirmed · clear filters

  1. WELL Health (now Artera) announced a $45 million Series C funding round led by Lead Edge Capital, 'bringing total funds raised to $75 million since its founding in 2015'; 'This year alone, WELL technology will enable 200k+ healthcare providers to send more than 1 billion messages with 30+ million patients' (Santa Barbara, Nov 24, 2020).

    Artera AI PlatformPress releaseUnverifiedOpen source ↗
    Provenance
    Claim ID
    clm_afafb585a4c60f0c7a5f
    Version
    1
    Workflow
    Patient Access & Contact Center AI
    Dimension
    economic value
    Retrieved
    2026-08-27
    Reviewer
    healthit-gate-v1
    Source URL
    https://artera.io/news/well-health-inc-secures-45-million-in-series-c-funding-to-transform-patient-communication-for-health-providers-payers-and-acos/
Know a source we are missing?

Checking feedback availability…

Open to everyone — no account needed. This is a non-PHI service: never include patient identifiers.

We cannot action an evidence claim without something to check.

Your message is privately delivered to the editorial team. How we handle your information.